Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Franceschini

Showing results (31-40 of 160) with videos related to

Pageof 16
Sort By:
Metabolism: Clinical and Experimental|May 1, 1981
Relation between the HDL apoproteins and AI isoproteins in subjects with the AIMilano abnormalityG Franceschini, M Sirtori, G Gianfranceschi, et al.
Biochimica Et Biophysica Acta|March 4, 1992
Apolipoprotein A-II modulates HDL remodeling in plasmaL Calabresi, C Banfi, C R Sirtori, et al.
Biochemical Pharmacology|March 16, 2010
Increased total and high density lipoprotein cholesterol with apoprotein changes resembling streptozotocin diabetes in tetrachlorodibenzodioxin (TCDD) treated ratsA Poli, G Franceschini, L Puglisi, et al.
The American Journal of Cardiology|July 25, 1988
Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucolC R Sirtori, M Sirtori, L Calabresi, et al.
The American Journal of Medicine|May 1, 1991
Management of lipoprotein-X accumulation in severe cholestasis by semi-selective LDL-apheresisG Franceschini, G Busnach, G Chiesa, et al.
Journal of Lipid Research|November 1, 1985
Effects of storage on the distribution of high density lipoprotein subfractions in human seraG Franceschini, C Tosi, Y Moreno, et al.
The Journal of Biological Chemistry|January 10, 1982
Genetic variants of group A apolipoproteins. Rapid methods for screening and characterization without ultracentrifugationG Utermann, G Feussner, G Franceschini, et al.
Pharmacological Research|October 1, 1992
Tolerability of fibric acids. Comparative data and biochemical basesC R Sirtori, L Calabresi, J P Werba, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 5, 2015
AMAROS Study: Overall Survival in Breast Cancer SubtypesA Orlandi, G Franceschini, A Astone, et al.
Metabolism: Clinical and Experimental|July 1, 1985
Cimetidine increases HDL-cholesterol, particularly in the HDL3 subfractionG Franceschini, G Montanari, C Cittella, et al.
Pageof 16

Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
Metabolism: Clinical and Experimental|May 1, 1981
Relation between the HDL apoproteins and AI isoproteins in subjects with the AIMilano abnormalityG Franceschini, M Sirtori, G Gianfranceschi, et al.
Biochimica Et Biophysica Acta|March 4, 1992
Apolipoprotein A-II modulates HDL remodeling in plasmaL Calabresi, C Banfi, C R Sirtori, et al.
Biochemical Pharmacology|March 16, 2010
Increased total and high density lipoprotein cholesterol with apoprotein changes resembling streptozotocin diabetes in tetrachlorodibenzodioxin (TCDD) treated ratsA Poli, G Franceschini, L Puglisi, et al.
The American Journal of Cardiology|July 25, 1988
Changes in high-density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucolC R Sirtori, M Sirtori, L Calabresi, et al.
The American Journal of Medicine|May 1, 1991
Management of lipoprotein-X accumulation in severe cholestasis by semi-selective LDL-apheresisG Franceschini, G Busnach, G Chiesa, et al.
Journal of Lipid Research|November 1, 1985
Effects of storage on the distribution of high density lipoprotein subfractions in human seraG Franceschini, C Tosi, Y Moreno, et al.
The Journal of Biological Chemistry|January 10, 1982
Genetic variants of group A apolipoproteins. Rapid methods for screening and characterization without ultracentrifugationG Utermann, G Feussner, G Franceschini, et al.
Pharmacological Research|October 1, 1992
Tolerability of fibric acids. Comparative data and biochemical basesC R Sirtori, L Calabresi, J P Werba, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 5, 2015
AMAROS Study: Overall Survival in Breast Cancer SubtypesA Orlandi, G Franceschini, A Astone, et al.
Metabolism: Clinical and Experimental|July 1, 1985
Cimetidine increases HDL-cholesterol, particularly in the HDL3 subfractionG Franceschini, G Montanari, C Cittella, et al.
Pageof 16